CIP2A antibody
Product Specifications
Background
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.
Synonyms
Protein CIP2A|Cancerous inhibitor of PP2A|p90 autoantigen|CIP2A|KIAA1524
Gene ID
57650
UniProt
Q8TCG1
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
KIAA1524
Target
CIP2A
Clonality
Polyclonal
Isotype
IgG
Applications
ELISA, WB
Purification
Immunogen affinity purified
Dilution
WB: 1:500 - 1:2000
Purity
≥95% as determined by SDS-PAGE
Form
Liquid
Molecular Weight
102 kDa
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
Tested Applications
ELISA, WB
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043345 200 µL
TSC2, phosphorylated (S1155) (Tsc2, Tuberin, Tuberous sclerosis 2 protein homolog)
Ask
View Details